Xspray Pharma AB Financial Overview
Xspray Pharma AB's market cap is currently €115.13M. The company's EPS TTM is €-0.15065375; its P/E ratio is -5.06; Xspray Pharma AB is scheduled to report earnings on November 5, 2025, and the estimated EPS forecast is €0.16. See an overview of income statement, balance sheet, and cash flow financials.
